Laurus Labs Limited has submitted a regulatory filing to BSE Limited and National Stock Exchange of India Ltd. intimating its schedule of analyst and institutional investor meetings. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will be participating in the following investor conferences through one-on-one meetings and group meetings:
- June 05, 2026: BofA Healthcare Tour in Hyderabad (In-Person Meeting)
- June 10, 2026: Macquarie Healthcare Tour in Hyderabad (In-Person Meeting)
The document includes two important notes:
1. The dates of the meetings are subject to change due to exigencies on the part of investors or the company.
2. The company confirms that no unpublished price sensitive information will be shared during these meetings.
The letter was digitally signed by VENKATESWAR REDDY GOGIREDDY on May 29, 2026, at 15:02:32 IST. The correspondence is from G. Venkateswar Reddy, who holds the position of Company Secretary & Compliance Officer at Laurus Labs Limited.